Log in | Register

Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsisOpen access

Erica L. T. van den Akker| Jan W. Koper| Koen Joosten| Frank H. de Jong| Jan A. Hazelzet| Steven W. J. Lamberts| Anita C. S. Hokken-Koelega
Original
Volume 35, Issue 7 / July , 2009

Pages 1247 - 1254

Abstract

Objective

Corticosteroids are used in sepsis treatment to benefit outcome. However, discussion remains on which patients will benefit from treatment. Inter-individual variations in cortisol sensitivity, mediated through the glucocorticoid receptor, might play a role in the observed differences. Our aim was to study changes in mRNA levels of three glucocorticoid receptor splice variants in neutrophils of children with sepsis.

Patients and design

Twenty-three children admitted to the pediatric intensive care unit with sepsis or septic shock were included. Neutrophils were isolated at days 0, 3 and 7, and after recovery (>3 months). mRNA levels of the glucocorticoid receptor splice variants GR-α (determining most of the cortisol effect), GR-P (increasing GR-α effect) and GR-β (inhibitor of GR-α) were measured quantitatively.

Main results

Neutrophils from sepsis patients showed decreased levels of glucocorticoid receptor mRNA of the GR-α and GR-P splice variants on day 0 compared to after recovery. GR-α and GR-P mRNA levels showed a gradual recovery on days 3 and 7 and normalized after recovery. GR-β mRNA levels did not change significantly during sepsis. GR expression was negatively correlated to interleukin-6 (a measure of disease severity, r = −0.60, P = 0.009).

Conclusions

Children with sepsis or septic shock showed a transient depression of glucocorticoid receptor mRNA in their neutrophils. This feature may represent a tissue-specific adaptation during sepsis leading to increased cortisol resistance of neutrophils. Our study adds to understanding the mechanism of cortisol sensitivity in immune cells. Future treatment strategies, aiming at timing and tissue specific regulation of glucocorticoids, might benefit patients with sepsis or septic shock.

Keywords

References

  1. Webster JI, Sternberg EM (2004) Role of the hypothalamic-pituitary-adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products. J Endocrinol 181:207–221
    • View reference on PubMed
    • View reference on publisher's website
  2. Jacobi J (2006) Corticosteroid replacement in critically ill patients. Crit Care Clin 22:245–253, vi
    • View reference on PubMed
    • View reference on publisher's website
  3. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124
    • View reference on PubMed
    • View reference on publisher's website
  4. Joosten KF, de Kleijn ED, Westerterp M, de Hoog M, Eijck FC, Hop WCJ, Voort EV, Hazelzet JA, Hokken-Koelega AC (2000) Endocrine and metabolic responses in children with meningoccocal sepsis: striking differences between survivors and nonsurvivors. J Clin Endocrinol Metab 85:3746–3753
    • View reference on PubMed
    • View reference on publisher's website
  5. den Brinker M, Joosten KF, Liem O, de Jong FH, Hop WC, Hazelzet JA, van Dijk M, Hokken-Koelega AC (2005) Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 90:5110–5117
    • View reference on publisher's website
  6. Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW (1998) Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J Clin Endocrinol Metab 83:47–54
    • View reference on PubMed
    • View reference on publisher's website
  7. Miller AH, Spencer RL, Pearce BD, Pisell TL, Azrieli Y, Tanapat P, Moday H, Rhee R, McEwen BS (1998) Glucocorticoid receptors are differentially expressed in the cells and tissues of the immune system. Cell Immunol 186:45–54
    • View reference on PubMed
    • View reference on publisher's website
  8. Prigent H, Maxime V, Annane D (2004) Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit Care 8:243–252
    • View reference on PubMed
    • View reference on publisher's website
  9. Zhou J, Cidlowski JA (2005) The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70:407–417
    • View reference on PubMed
    • View reference on publisher's website
  10. van den Akker EL, Koper JW, van Rossum EF, Dekker MJ, Russcher H, de Jong FH, Uitterlinden AG, Hofman A, Pols HA, Witteman JC, Lamberts SW (2008) Glucocorticoid receptor gene and risk of cardiovascular disease. Arch Intern Med 168:33–39
    • View reference on PubMed
    • View reference on publisher's website
  11. van den Akker EL, Nouwen JL, Melles DC, van Rossum EF, Koper JW, Uitterlinden AG, Hofman A, Verbrugh HA, Pols HA, Lamberts SW, van Belkum A (2006) Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J Infect Dis 194:814–818
    • View reference on PubMed
    • View reference on publisher's website
  12. van den Akker EL, Russcher H, van Rossum EF, Brinkmann AO, de Jong FH, Hokken A, Pols HA, Koper JW, Lamberts SW (2006) Glucocorticoid receptor polymorphism affects transrepression but not transactivation. J Clin Endocrinol Metab 91:2800–2803
    • View reference on PubMed
    • View reference on publisher's website
  13. van Rossum EF, Lamberts SW (2004) Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 59:333–357
    • View reference on PubMed
    • View reference on publisher's website
  14. Schaaf MJ, Cidlowski JA (2002) AUUUA motifs in the 3’UTR of human glucocorticoid receptor alpha and beta mRNA destabilize mRNA and decrease receptor protein expression. Steroids 67:627–636
    • View reference on PubMed
    • View reference on publisher's website
  15. de Lange P, Segeren CM, Koper JW, Wiemer E, Sonneveld P, Brinkmann AO, White A, Brogan IJ, de Jong FH, Lamberts SW (2001) Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Res 61:3937–3941
    • View reference on PubMed
  16. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP (1995) Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95:2435–2441
    • View reference on PubMed
    • View reference on publisher's website
  17. Pujols L, Xaubet A, Ramirez J, Mullol J, Roca-Ferrer J, Torrego A, Cidlowski JA, Picado C (2004) Expression of glucocorticoid receptors alpha and beta in steroid sensitive and steroid insensitive interstitial lung diseases. Thorax 59:687–693
    • View reference on PubMed
    • View reference on publisher's website
  18. Lu NZ, Cidlowski JA (2004) The origin and functions of multiple human glucocorticoid receptor isoforms. Ann N Y Acad Sci 1024:102–123
    • View reference on PubMed
    • View reference on publisher's website
  19. Sun X, Fischer DR, Pritts TA, Wray CJ, Hasselgren PO (2002) Expression and binding activity of the glucocorticoid receptor are upregulated in septic muscle. Am J Physiol Regul Integr Comp Physiol 282:R509–R518
    • View reference on PubMed
  20. Goecke IA, Alvarez C, Henriquez J, Salas K, Molina ML, Ferreira A, Gatica H (2007) Methotrexate regulates the expression of glucocorticoid receptor alpha and beta isoforms in normal human peripheral mononuclear cells and human lymphocyte cell lines in vitro. Mol Immunol 44:2115–2123
    • View reference on PubMed
    • View reference on publisher's website
  21. Molijn GJ, Spek JJ, van Uffelen JC, de Jong FH, Brinkmann AO, Bruining HA, Lamberts SW, Koper JW (1995) Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metab 80:1799–1803
    • View reference on PubMed
    • View reference on publisher's website
  22. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF (2006) Neutrophils in development of multiple organ failure in sepsis. Lancet 368:157–169
    • View reference on PubMed
    • View reference on publisher's website
  23. Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2–8
    • View reference on PubMed
    • View reference on publisher's website
  24. Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116
    • View reference on PubMed
  25. van den Akker EL, Baan CC, van den Berg B, Russcher H, Joosten K, Hokken-Koelega AC, Lamberts SW, Koper JW (2008) Ficoll-separated mononuclear cells from sepsis patients are contaminated with granulocytes. Intensive Care Med 34:912–916
  26. Russcher H, Smit P, van den Akker EL, van Rossum EF, Brinkmann AO, de Jong FH, Lamberts SW, Koper JW (2005) Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J Clin Endocrinol Metab 90:5804–5810
    • View reference on PubMed
    • View reference on publisher's website
  27. van den Akker EL, Koper JW, Joosten K, De Jong FH, Hazelzet JA, Lamberts SW, Hokken-Koelega AC (2007) Glucocorticoid receptor expression is decreased in granulocytes of sepsis patients. Poster, ESPE Annual Meeting, Helsinki
  28. Marshall JC (2005) Neutrophils in the pathogenesis of sepsis. Crit Care Med 33:S502–S505
    • View reference on PubMed
    • View reference on publisher's website
  29. Liberman AC, Druker J, Perone MJ, Arzt E (2007) Glucocorticoids in the regulation of transcription factors that control cytokine synthesis. Cytokine Growth Factor Rev 18:45–46
    • View reference on PubMed
    • View reference on publisher's website
  30. Ahmed NA, McGill S, Yee J, Hu F, Michel RP, Christou NV (1999) Mechanisms for the diminished neutrophil exudation to secondary inflammatory sites in infected patients with a systemic inflammatory response (sepsis). Crit Care Med 27:2459–2468
    • View reference on PubMed
    • View reference on publisher's website
  31. Duma D, Silva-Santos JE, Assreuy J (2004) Inhibition of glucocorticoid receptor binding by nitric oxide in endotoxemic rats. Crit Care Med 32:2304–2310
    • View reference on PubMed
  32. Stith RD, McCallum RE (1983) Down regulation of hepatic glucocorticoid receptors after endotoxin treatment. Infect Immun 40:613–621
    • View reference on PubMed
  33. Sun X, Mammen JM, Tian X (2003) Sepsis induces the transcription of the glucocorticoid receptor in skeletal muscle cells. Clin Sci (Lond) 105:383–391
  34. Strickland I, Kisich K, Hauk PJ, Vottero A, Chrousos GP, Klemm DJ, Leung DY (2001) High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 193:585–593
    • View reference on PubMed
    • View reference on publisher's website
  35. Xu Q, Leung DY, Kisich KO (2003) Serine-arginine-rich protein p30 directs alternative splicing of glucocorticoid receptor pre-mRNA to glucocorticoid receptor beta in neutrophils. J Biol Chem 278:27112–27118
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement